Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, June 30, 2025.
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR)
Long-Term Uptrend (+90) - CTXR is in a strong uptrend that is likely to continue. While CTXR is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid CTXR?
MarketClub looks at technical strength and momentum to determine if the timing is right for CTXR.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CTXR
The long-term trend has been UP since Jun 9th, 2025 at 2.28000
The intermediate-term trend has been UP since May 14th, 2025 at 0.95410
The short-term trend has been UP since Jun 18th, 2025 at 0.91839
Smart Scan Analysis for CTXR
Based on our trend formula, CTXR is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 1.750 | 1.860 | 1.540 | 1.595 | +0.065 |
| Prev. Close | Volume | Bid | Ask | Time |
| 1.530 | 2635843 | 2025-06-30 15:59:37 |
| Year High | 4.6 | Year High Date | 2018-01-26 |
| Year Low | 1.1081 | Year Low Date | 2018-11-26 |
| 52wk High | 26.25 | 52wk High Date | 2024-08-06 |
| 52wk Low | 0.65 | 52wk Low Date | 2025-05-08 |
| Average Volume | 6,703,792 | Shares Outstanding | 10,290 |
| Market Cap | 23M | Assets | 121,481,411M |
| Liabilities | 60,821,999M | P/E Ratio | -0.69170000 |
| Volatility | 45.99 |